Back to Trades
Grant4
Jazz Pharmaceuticals plc
JAZZ
Total Value
$0
Company Information
- Company Name
- Jazz Pharmaceuticals plc
- Ticker Symbol
- JAZZ
- CIK
- 0001232524
Insider Information
- Name
- Iannone Robert
- Role
- EVP, Global Head of R&D & CMO
- Location
- DUBLIN 4, L2
Officer
Filing Details
- Filing Date
- Mar 2, 2026
- Transaction Date
- Feb 26, 2026
- Accession Number
- 0001737329-26-000004
- Form Type
- 4
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Feb 26, 2026 | Ordinary Shares | 14,822 | — | Grant/Award | — |
Footnotes
- (F1)These restricted stock units are granted pursuant to the Issuer's 2011 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. These units vest in equal annual installments over four years measured from the vesting commencement date of March 5, 2026, with 1/4th vesting on the first anniversary of the vesting commencement date and the remainder vesting in equal annual installments over the subsequent three years.